{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:43:43Z","timestamp":1793832223297,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jvoice.2024.02.011","type":"journal-article","created":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T03:06:58Z","timestamp":1710558418000},"page":"1146-1153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Meta-analysis of PPIs Plus Alginate Versus PPIs Alone for the Treatment of GERD"],"prefix":"10.1016","volume":"40","author":[{"given":"Xinyue","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyun","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2024.02.011_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/apt.12482","article-title":"Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease","volume":"38","author":"Chiu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.02.011_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5056\/jnm21095","article-title":"On-demand versus continuous maintenance treatment of gastroesophageal reflux disease with proton pump inhibitors: a systematic review and meta-analysis","volume":"28","author":"Kang","year":"2022","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.jvoice.2024.02.011_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11894-011-0192-x","article-title":"GERD-related cough: pathophysiology and diagnostic approach","volume":"13","author":"Smith","year":"2011","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jvoice.2024.02.011_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00405-016-3984-7","article-title":"Voice outcomes of laryngopharyngeal reflux treatment: a systematic review of 1483 patients","volume":"274","author":"Lechien","year":"2017","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvoice.2024.02.011_bib5","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/MEG.0b013e32830a70e2","article-title":"The Italian validation of the Montreal Global definition and classification of gastroesophageal reflux disease","volume":"21","author":"Pace","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2024.02.011_bib6","series-title":"StatPearls","article-title":"Laryngopharyngeal reflux","author":"Brown","year":"2024"},{"key":"10.1016\/j.jvoice.2024.02.011_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9105814","article-title":"Meta-analysis of proton pump inhibitors in the treatment of pharyngeal reflux disease","volume":"2022","author":"Jin","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.jvoice.2024.02.011_bib8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.cgh.2014.04.003","article-title":"Proton pump inhibitors reduce the size and acidity of the acid pocket in the stomach","volume":"12","author":"Rohof","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2024.02.011_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002095.pub3","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","volume":"3","author":"van Pinxteren","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jvoice.2024.02.011_bib10","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S1542-3565(04)00288-5","article-title":"Effectiveness of proton pump inhibitors in nonerosive reflux disease","volume":"2","author":"Dean","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2024.02.011_bib11","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/0194599819827488","article-title":"Evaluation and management of laryngopharyngeal reflux disease: state of the art review","volume":"160","author":"Lechien","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2024.02.011_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1053\/gast.2001.27997","article-title":"Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal","volume":"121","author":"Fletcher","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvoice.2024.02.011_bib13","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/ajg.2013.132","article-title":"The acid pocket: a target for treatment in reflux disease?","volume":"108","author":"Kahrilas","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvoice.2024.02.011_bib14","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.cgh.2013.04.046","article-title":"An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease","volume":"11","author":"Rohof","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jvoice.2024.02.011_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/apt.12318","volume":"37","author":"Sweis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.02.011_bib16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/apt.14064","article-title":"Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms","volume":"45","author":"Coyle","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.02.011_bib17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.5009\/gnl18378","article-title":"The clinical efficacy of a pure alginate formulation (Lamina G) for controlling symptoms in individuals with reflux symptoms: a randomized clinical study","volume":"13","author":"Kim","year":"2019","journal-title":"Gut Liver"},{"key":"10.1016\/j.jvoice.2024.02.011_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1442-2050.2011.01276.x","article-title":"Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial","volume":"25","author":"Manabe","year":"2012","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jvoice.2024.02.011_bib19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/apt.13567","article-title":"Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor","volume":"43","author":"Reimer","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.02.011_bib20","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/apt.14064","article-title":"Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms","volume":"45","author":"Coyle","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jvoice.2024.02.011_bib21","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3748\/wjg.v16.i19.2323","article-title":"Safety of the long-term use of proton pump inhibitors","volume":"16","author":"Thomson","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jvoice.2024.02.011_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13735","article-title":"Exacerbation of gastroesophageal reflux symptoms after discontinuation of proton pump inhibitors is not associated with increased esophageal acid exposure","volume":"32","author":"Hoshikawa","year":"2020","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jvoice.2024.02.011_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00535-022-01861-z","article-title":"Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021","volume":"57","author":"Iwakiri","year":"2022","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jvoice.2024.02.011_bib24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/lary.26696","article-title":"Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease","volume":"128","author":"Lin","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2024.02.011_bib25","article-title":"Laryngopharyngeal reflux disease and gastroesophageal reflux disease can mutually influence","author":"Wang","year":"2022","journal-title":"J Voice"},{"key":"10.1016\/j.jvoice.2024.02.011_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1749-4486.2011.02394.x","article-title":"Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon\u00ae Advance: how we do it","volume":"36","author":"Lieder","year":"2011","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jvoice.2024.02.011_bib27","first-page":"004","article-title":"Laryngopharyngeal reflux\u2013a randomized clinical controlled trial","volume":"1","author":"Pedersen","year":"2012","journal-title":"Otolaryngology"},{"key":"10.1016\/j.jvoice.2024.02.011_bib28","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s00405-018-5079-0","article-title":"Gaviscon\u00ae Advance alone versus co-prescription of Gaviscon\u00ae Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux","volume":"275","author":"Wilkie","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199724000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199724000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:31:09Z","timestamp":1783423869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199724000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0892199724000328"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2024.02.011","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Meta-analysis of PPIs Plus Alginate Versus PPIs Alone for the Treatment of GERD","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2024.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Voice Foundation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}